CAS: 186497-67-6; 4-Propoxyphenylboronic Acid

上下游产品

CAS号39969-56-7 1-溴-4-丙氧基苯 | CAS号106-41-2 对溴苯酚

4-N-丙氧基溴苯置于正丁基锂,硼酸三乙酯,盐酸,水体系中,用 四氢呋喃 用作溶剂,化学反应生成4-丙氧基苯硼酸
参考文献:溴化噻吩作为制备溴化和芳基化蒽醌的前体
标题:溴化噻吩作为制备溴化和芳基化蒽醌的前体
摘要:当溴噻吩与 1,4-萘醌在间氯过氧苯甲酸存在下反应时,可以直接合成溴化蒽醌.溴蒽醌是制备芳基蒽醌和具有散布蒽醌单元的扩展 π 系统的通用构件.
Doi:10.3390/molecules14031013

专利信息

专利号:WO-2023167325-A1
优先权日:2022-03-03
标 题 :Immobilized palladium catalyst and method for producing same, and application of this catalyst to coupling reaction
发明人：YAMADA YOICHI; ZHANG ZHENZHONG; OHNO AYA
权利人:RIKEN
摘要:The present invention addresses the problem of developing a metal catalyst which is suitable for continuous flow organic synthesis reaction, is excellent in durability, and has high activity.　The present invention provides an immobilized palladium catalyst comprising a complex composed of palladium and a copolymer formed from (A) a repeating unit that has a certain substituted aromatic hydrocarbon ring and (B) a repeating unit that has a certain nitrogen-containing aromatic hetero ring.

专利号:US-8178559-B2
优先权日:2004-12-30
标 题:Organic compounds
发明人：BREITENSTEIN WERNER; EHARA TAKERU; EHRHARDT CLAUS; GROSCHE PHILIPP; HITOMI YUKO; IWAKI YUKI; KANAZAWA TAKANORI; KONISHI KAZUHIDE; MAIBAUM JUERGEN KLAUS; MASUYA KEIICHI; IWASAKI ATSUKO; OSTERMANN NILS; SUZUKI MASAKI; TOYAO ATSUSHI; YOKOKAWA FUMIAKI
权利人:BREITENSTEIN WERNER; EHARA TAKERU; EHRHARDT CLAUS; GROSCHE PHILIPP; HITOMI YUKO; IWAKI YUKI; KANAZAWA TAKANORI; KONISHI KAZUHIDE; MAIBAUM JUERGEN KLAUS; MASUYA KEIICHI; IWASAKI ATSUKO; OSTERMANN NILS; SUZUKI MASAKI; TOYAO ATSUSHI; YOKOKAWA FUMIAKI; NOVARTIS AG
摘要:3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4substituted piperidine compound, a method for the manufacture of a 3,4-substituted piperidine compound, and novel intermediates and partial steps for their synthesis are disclosed. The 3,4-disubstituted piperidine compounds have the formula (I), wherein the symbols have the meanings defined in the specification.